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Objective: To analyze the maternal and perinatal characteristics of small-for-gestational-age (SGA) newborns compared with appropriate-for-
gestational-age (AGA) newborns in singleton pregnancies managed at our hospital between January 2006 and December 2015. 
Material and Methods: The study (n=456) and control (n=4925) groups included pregnancies resulting in SGA and AGA newborns, respectively. 
Additionally, two SGA subgroups were defined according to abnormal (n=34) and normal (n=57) Doppler findings. Maternal demographic 
features; intracytoplasmic sperm injection (ICSI) pregnancies; gestational age at delivery; birth weight; major congenital anomalies, karyotype 
abnormalities, and genetic syndromes; maternal and obstetric problems such as hypertensive disorders, diabetes, oligohydramnios, preterm 
birth; admission to the neonatal intensive care unit (NICU), and perinatal mortality were recorded, and the two groups were compared with 
respect to these parameters. 
Results: Mean maternal age, parity, gestational age at delivery, and birthweight were significantly lower; the frequencies of ICSI pregnancies, 
hypertensive disorders, oligohydramnios, preterm delivery, major congenital anomalies, karyotype abnormalities and genetic syndromes, 
admission to the NICU and perinatal mortality were significantly higher in the study group (p<0.05). None of the study parameters were 
significantly different between the two SGA subgroups (p>0.05). 
Conclusion: The association of SGA with ICSI pregnancies, hypertensive disorders, oligohydramnios, preterm delivery, congenital/chromosomal 
anomalies, NICU admission and perinatal mortality may be important in perinatal care. Clinical suspicion of SGA necessitates appropriate 
monitorization and management. Although obstetric outcomes were not significantly different between the two SGA subgroups with abnormal 
and normal Doppler findings in this study, this finding must be evaluated with caution due to the small sizes. (J Turk Ger Gynecol Assoc 2017; 
18: 90-5)
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Introduction
Small for gestational age (SGA) newborns are defined as 
birthweight <10th percentile according to the gestational 
age (1). Although constitutional factors such as female sex, 
ethnicity, parity or maternal body mass index, might be 
the cause in most SGA newborns, various maternal, fetal 
or placental disorders may play role in the remainder. This 
latter group encompasses newborns with intrauterine growth 
restriction (IUGR), or in other words, fetal growth restriction 
(FGR) (2). Not all, but some cases of pathologic SGA may 
be differentiated from constitutional cases according to the 
presence of ultrasonographic findings such as declining fetal 
growth curve, oligohydramnios, abnormal Doppler indices, 
biometric measurements <3rd percentile, as well as abnormal 
fetal anatomy (3). Nevertheless, several studies indicate 
that, SGA as a whole group, is associated with an increased 
risk of both neonatal morbidity, including respiratory distress 
syndrome, intraventricular hemorrhage, seizure, sepsis and 
perinatal mortality (4). Thus, the management of SGA fetuses 
and newborns differ from those that are appropriate for 
gestational age (AGA) due to the increased risk of perinatal and 
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neonatal adverse outcomes. The effects of SGA are observed 
in the immediate neonatal period and in infancy, childhood, 
and adulthood. Long-term adverse outcomes such as 
neurocognitive impairment, obesity, type 2 diabetes mellitus, 
hypertension, and cardiovascular diseases are more frequently 
emphasized in recent studies (5, 6).
The aim of this study was to analyze the maternal and perinatal 
characteristics of small-for-gestational age-newborns compared 
with appropriate-for-gestational-age newborns in singleton 
pregnancies managed at our hospital between January 2006 
and December 2015. The data obtained in this study may recall 
attention to the early suspicion and management of SGA in 
daily obstetric practice.
Material and Methods
This study was approved by the Institutional Review Board and 
Ethics Committee of Başkent University. Başkent University 
Ankara Hospital delivery records and patients' files between 
January 2006 and December 2015 were retrospectively analyzed 
to determine SGA and AGA newborns. Only singletons were 
evaluated (n=5757) excluding twin and triplet pregnancies. 
SGA was defined as birthweight <10th percentile and AGA was 
defined as birthweight between the 10th and 90th percentiles 
with respect to gestational age (7). The study group included 
456 SGA newborns and the control group comprised 4925 AGA 
newborns. Maternal demographic features; intracytoplasmic 
sperm injection (ICSI) pregnancies; advanced maternal age; 
gestational age at delivery; birth weight; major congenital 
anomalies, karyotype abnormalities and genetic syndromes; 
maternal and obstetric problems such as hypertensive disorders, 
diabetes, oligohydramnios, preterm birth; admission to the 
neonatal intensive care unit (NICU), and perinatal mortality were 
recorded and the two groups were compared with respect to 
these parameters. Maternal age ≥35 years at birth was accepted 
as advanced maternal age. Chronic hypertension, gestational 
hypertension, preeclampsia, eclampsia, and superimposed 
preeclampsia were considered as maternal hypertensive 
disorders. Maternal diabetes included pregestational and 
gestational diabetes. When the deepest single pocket of 
amniotic fluid was measured as <2 cm at the second or third 
trimester ultrasonography, it was accepted as oligohydramnios. 
Preterm birth was defined as deliveries less than 37 gestational 
weeks. Perinatal mortality included intrauterine, intrapartum, 
and neonatal deaths within the postpartum first 28 days. 
Doppler ultrasonography examinations of the study group 
including SGA newborns were also evaluated; however, we 
were not able to obtain the examination results of most of the 
cases because of the retrospective design of the study, and 
due to the renewal of the electronic recording system of the 
hospital. Thus, two subgroups were defined as abnormal and 
normal Doppler findings including 34 and 57 cases, respectively. 
Doppler examinations were accepted as abnormal when 
at least one of the following findings were present at any 
gestational age ≥24 weeks: umbilical artery (UA) S/D ratio 
>95th percentile; pulsatility index (PI) >95th percentile; absent 
or reversed end-diastolic flow (AREDF) in the UA; absent or 
reversed a-wave in ductus venosus (DV); and cerebroplacental 
ratio (CPR) was defined as middle cerebral artery (MCA) PI/UA 
PI <5th percentile. The maternal and perinatal characteristics 
mentioned before were compared between the two SGA 
subgroups with abnormal and normal Doppler findings. 
Statistical analysis was performed using SPSS for Windows, 
version 22.0. Mann-Whitney U, χ2, and Fisher’s exact tests were 
used where appropriate. A p value of <.05 was considered 
statistically significant.
Results 
The frequency of the SGA newborns among singletons was 
7.92% (456/5757) between January 2006 and December 2015 at 
Başkent University Hospital.
The mean maternal age, parity, gestational age at delivery 
and birth weight were significantly lower in the study group 
with SGA compared with the control group (30.61±5.25 vs. 
31.11±4.63; 0.41±0.66 vs. 0.49±0.68; 37.01±3.42 vs. 38.04±2.37 
and 2310.45±605.66 vs. 3222.91±502.11, respectively, (p<.05). 
There was no significant difference between the study and the 
control groups with respect to gravidity (p>.05) (Table 1).
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Table 1. Demographic features of the study and control groups
Study group (SGA) n=456
Mean ± SD (range)
Control group (AGA) n=4925
Mean ± SD (range)
p
Maternal age (years) 30.61±5.25 (18-58) 31.11±4.63 (16-49) <.05
Gravidity 1.75±1.07 (1-9) 1.83±1.07 (0-11) >.05
Parity 0.41±0.66 (0-5) 0.49±0.68 (0-8) <.05
Gestational age at delivery (weeks) 37.01±3.42 (20-42) 38.04±2.37 (20-42) <.05
Birth weight (grams) 2310.45±605.66 (240-2920) 3222.91±502.11(310-4090) <.05
Mann-Whitney U test
SD: standard deviation; SGA: small for gestational age; AGA: appropriate for gestational age
When the two groups were compared with respect to risk 
factors for SGA and obstetric outcomes, it was observed 
that the rates of ICSI pregnancies, hypertensive disorders, 
oligohydramnios, preterm delivery, major congenital anomaly/
chromosomal anomaly/syndrome were significantly higher in 
the study group (12.3% vs. 8%; 12.9% vs. 3.6%; 12.3% vs. 3.1%; 
22.6% vs. 10.6% and 8.8% vs. 4.2%, respectively, p<.05). NICU 
admission and perinatal mortality were also significantly more 
frequent in the study group (26.7% vs. 8.4% and 5.3% vs. 1.2%, 
respectively, p<.05) (Table 2). Perinatal mortality was due to 
intrauterine exitus, anomaly-related mortality, and prematurity-
related mortality in 25%, 33.3%, and 41.7% of cases in the study 
group, whereas it was 15%, 58.3%, and 26.7% in the control 
group, respectively. There were no significant differences 
between the study and control groups with respect to advanced 
maternal age and diabetes (p>.05) (Table 2). 
In the subgroup analyses of SGA newborns with abnormal and 
normal Doppler findings, there were no significant differences 
in the mean maternal age, gravidity, parity, gestational age at 
delivery, and birth weight (p>.05) (Table 3). 
The rates of risk factors and adverse obstetric outcomes, 
including ICSI pregnancies, hypertensive disorders, 
oligohydramnios, preterm delivery, major congenital anomaly/
chromosomal anomaly/ syndrome, NICU admission, and 
perinatal mortality, did not significantly differ between the two 
SGA subgroups with abnormal and normal Doppler findings 
(p>.05) (Table 4). 
Discussion
Whether the topic is ‘small for gestational age’ or ‘fetal growth 
restriction’ the complexity of the definitions must be kept 
in mind while reviewing the literature. SGA is accepted as 
birthweight <10th percentile according to the gestational age 
using a population-based reference. The diagnosis of SGA 
would be more accurate if population-based birthweight 
standards were determined with healthy mothers without 
risk factors for FGR. Some studies in the literature used their 
own birthweight nomograms, whereas others, as in this study, 
used a different population-based nomogram (2, 4, 8). There 
are various single-center studies from Turkey that evaluated 
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Table 2. Risk factors for small-for-gestational-age newborns and obstetric outcomes in the study and control 
groups
Study group (SGA)
Rate (%)
Control group (AGA)
Rate (%)
p
Advanced maternal age 99/456 (21.7) 1139/4925 (23.1) >.05
ICSI pregnancies 56/456 (12.3) 393/4925 (8) <.05
Hypertensive disorders 59/456 (12.9) 178/4925 (3.6) <.05
Diabetes 35/456 (7.7) 349/4925 (7) >.05
Oligohydramnios 56/456 (12.3) 154/4925 (3.1) <.05
Preterm delivery 103/456 (22.6) 524/4925 (10.6) <.05
Major congenital anomaly/chromosomal anomaly/syndrome 40/456 (8.8) 206/4925 (4.2) <.05
NICU admission  122/456 (26.7) 411/4925 (8.4) <.05
Perinatal mortality 24/456 (5.3) 60/4925 (1.2) <.05
χ2 test
SGA: small for gestational age; AGA: appropriate for gestational age; NICU: neonatal intensive care unit; ICSI: intracytoplasmic sperm injection
Table 3. Demographic features of small-for-gestational-age newborns with abnormal and normal Doppler 
findings
Abnormal Doppler n=34
Mean ± SD (range)
Normal Doppler n=57
Mean ± SD (range)
p
Maternal age (years) 31.03±5.22 (20-39) 30.7±5.37 (18-47) >.05
Gravidity 1.59±0.98 (1-5) 1.67±0.89 (1-4) >.05
Parity 0.32±0.63 (0-2) 0.33±0.63 (0-3) >.05
Gestational age at delivery (weeks) 36.5±2.98 (29-40) 37.37±2.61 (27-41) >.05
Birth weight (grams) 2148.68±612.96 (680-2890) 2362.44±464.27 (605-2920) >.05
Mann-Whitney U test
SD: standard deviation; SGA: small for gestational age
birthweight distribution, which probably cannot be generalized 
to the whole Turkish population (9, 10). Therefore, although 
it is a limitation of this study, we selected a population-based 
reference from the United States of America, which was 
determined to be the most powerful and most contemporary 
of the growth curves available (7).
The frequency of SGA newborns ranges widely from 3.5% 
to 17.9% in several studies in the literature due the different 
definitions and references used (2, 11). The rate of SGA 
newborns in our study appeared as 7.92%.
The current study aimed to compare the maternal and 
perinatal characteristics of the SGA newborns with those of 
AGA newborns in a single center within a ten-year period. By 
definition, the SGA group may include both constitutionally 
small but healthy newborns and those who are pathologically 
small; however, regarding the perinatal outcome, these 
two groups of SGA babies may differ from each other (12). 
On the other hand, the AGA group may also include both 
normal babies and babies who are unable to reach their 
biologic growth potential. Even though both SGA and AGA 
groups may include disordered babies, this proportion is 
expected to be much smaller in the AGA group, and reports 
in the literature agree in that perinatal morbidity and mortality 
rates in SGA newborns are higher (13, 14). Perinatal mortality 
was 5.3% (24/456) in the SGA group in our study, and it was 
significantly higher when compared with the 1.2% (60/4925) 
in the AGA group (Table 2). Perinatal morbidity such as sepsis, 
respiratory distress syndrome, bronchopulmonary dysplasia, 
intraventricular hemorrhage, necrotizing enterocolitis, 
retinopathy of prematurity, hypoxic ischemic encephalopathy, 
hypoglycemia, hyperbilirubinemia, and polycythemia might 
be observed more commonly in SGA newborns (15). In our 
retrospective data, we were not able to analyze the perinatal 
morbidity in the study and control groups in detail; however, 
the frequency of NICU admission was significantly higher 
in the SGA group, and this may indirectly reflect a higher 
morbidity rate.
Risk factors for SGA may be listed as follows: constitutionally 
small mothers; poor maternal nutrition; maternal and 
fetal infections; congenital malformations; chromosomal 
aneuploidies; inherited syndromes; tobacco, alcohol or illegal 
drug use; vascular disease; pregestational diabetes; chronic 
hypoxia; anemia; placental and cord abnormalities; and 
infertility (16).
In our study, the rates of ICSI pregnancies and major congenital 
anomalies/chromosomal anomalies/syndromes were 
significantly higher in the SGA group compared with the AGA 
group, in accordance with the literature (16-18). Zhu et al. 
(18) and Valenzuela-Alcaraz et al. (19) reported an increased 
incidence of SGA infants in women with a history of infertility 
with or without infertility treatment, and Valenzuela-Alcaraz et 
al. (19) also described a preferential association of SGA with 
treated infertility, either by ovulation induction or ICSI. We 
were not able to compare the study and control groups with 
respect to this parameter because the history of infertility was 
not recorded in our data; thus, we can only say that ICSI is a risk 
factor for SGA, either by itself or due to the history of infertility, 
not specified in our study. 
Regarding maternal age, some studies defined young age and 
some defined advanced age as risk factors for SGA, whereas 
others failed to find any association (2). In our study, mean 
maternal age and parity were significantly lower in the SGA 
group and advanced maternal age did not appear to be a risk 
factor. It is generally accepted that nulliparity increases the risk 
of SGA infants when compared with multiparity, which may be 
considered as in accordance with our study (20, 21); however, 
conflicting results have also been reported (2). 
In this study, the rate of hypertensive disorders was significantly 
higher in the SGA group compared with the AGA group, 
which is consistent with the results of various studies in the 
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Table 4. Risk factors and obstetric outcomes of the small-for-gestational-age newborns with abnormal and 
normal Doppler findings
Abnormal Doppler n=34
Rate (%)
Normal Doppler n=57
Rate (%)
p
ICSI newborns 7/34 (20.5) 13/57 (22.8) >.05
Hypertensive disorders 7/34 (20.5) 8/57 (14.0) >.05
Diabetes mellitus 6/34 (17.7) 5/57 (8.7) >.05
Oligohydramnios 5/34 (14.7) 11/57 (19.2) >.05
Preterm delivery 12/34 (35.2) 10/57 (17.5) >.05
Major congenital anomaly/chromosomal anomaly/syndrome 7/34 (20.5) 9/57 (15.7) >.05
NICU admission 15/34 (44.1) 17/57 (29.8) >.05
Perinatal mortality 1/34 (2.9) 2/57 (3.5) >.05
NICU: neonatal intensive care unit; ICSI: intracytoplasmic sperm injection
literature (22-24). Another comorbidity evaluated in our study 
was diabetes, including both pregestational and gestational 
diabetes, and the rate did not differ significantly between the 
study and control groups. In the literature, it is reported that 
diabetes with vasculopathy was associated with increased 
SGA (25). Also, Langer et al. (26) suggested that a relationship 
existed between the level of glycemic control and neonatal 
weight, which means that poor glycemic control is associated 
with large-for-gestational-age babies, whereas stringent 
glycemic control is associated with SGA babies. 
The rate of oligohydramnios was significantly higher in the SGA 
group in our study; although we did not separately evaluate 
the subgroup with placental insufficiency as the underlying 
etiology, it is known that oligohydramnios mostly accompanies 
in this circumstance (27). 
The preterm delivery rate in our study was significantly higher 
in the SGA group (22.6%) compared with the AGA group, 
although not classified as iatrogenic or spontaneous. It is well 
known that SGA is one of the most common indications for 
medical intervention resulting in preterm birth (28). FGR has 
also been recognized as a cause in spontaneous preterm 
labor and suggests a fetal role (29). Placental insufficiency and 
inadequate perfusion of the fetus might result in fetal distress 
and premature activation of the hypothalamo-pituitary-adrenal 
axis.
Abnormal Doppler indices may be useful to differentiate 
fetuses with pathologic growth restriction due to placental 
insufficiency, from those that are constitutionally small but 
normal. For subgroup analyses, we were able to document 
the Doppler studies of only 91 SGA newborns out of 456. When 
we analyzed the subgroups of SGA with abnormal (n=34) 
and normal (n=57) Doppler indices, there were no significant 
differences with respect to the study parameters, namely: 
maternal demographic features and rates of ICSI pregnancies, 
hypertensive disorders, oligohydramnios, preterm delivery, 
major congenital anomaly/chromosomal anomaly/syndrome, 
NICU admission, and perinatal mortality. Therefore, according 
to our results, abnormal Doppler findings were not significantly 
more common in SGA newborns with adverse outcomes such 
as preterm delivery, major congenital anomaly/chromosomal 
anomaly/syndrome, NICU admission or perinatal mortality. 
However, this finding must be evaluated with caution due to the 
small sizes of the subgroups. One other limitation of our study 
is that we were not able to analyze and compare the obstetric 
outcomes according to each Doppler abnormality separately, 
again because of the small sample size. Unterscheider et al. 
(30) reported that Doppler interrogation of the UA and MCA 
remained the most useful tool in identifying fetuses at risk 
of adverse perinatal outcome, capturing 88% of all adverse 
outcomes; however, management of SGA fetuses is more 
complex and Doppler indices, biophysical profile scoring, 
amniotic fluid volume, and maternal health status might be in 
consideration. 
The present study could not give any results about specific 
morbidities and long-term health outcomes of SGA newborns. 
As we had to analyze the data retrospectively. We were not able 
to document and evaluate all risk factors including tobacco, 
alcohol or illegal drug use; previous SGA child; weight gain 
during pregnancy; body mass index; socioeconomic status, 
and numbers of prenatal visits. 
In conclusion, the definition, management, and timing of 
delivery of SGA fetuses are still under debate. This study aimed 
to determine risk factors associated with SGA that might 
either be known preconceptionally or in the earlier weeks of 
gestation, or be recognized during antenatal follow-up, as well 
as the possible adverse outcomes awaiting SGA newborns. ICSI 
pregnancies and mothers with known hypertensive disorders 
might be followed-up more closely with respect to the increased 
risk of SGA. In the case of SGA, oligohydramnios, gestational 
hypertensive disorders, major congenital or chromosomal 
anomalies or syndromes can be more commonly encountered 
and these clinical conditions might already be present before 
the appearance of abnormal biometric measurements and 
Doppler findings, or might be diagnosed later. More detailed 
anatomic screening of fetuses with SGA may provide to 
identify the anomalies; on the other hand, oligohydramnios 
or hypertension may be clues for recognizing SGA. According 
to the results of our study, regarding perinatal outcomes of 
SGA newborns, preterm birth, NICU admission and perinatal 
mortality risks are increased; therefore, the delivery of these 
fetuses must be planned at appropriate centers. 
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